Clinical Trial: Clinical Efficacy of Teprotumumab in Elderly Patients (>=60 Years Old) with Thyroid Eye Disease: A Prospective Observational Registry Study (China)

China, Sept. 3 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Efficacy of Teprotumumab in Elderly Patients (>=60 Years Old) with Thyroid Eye Disease: A Prospective Observational Registry Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131450

Registration Time: 2026/09/02

Type: Observational study

Primary Sponsor: China National Nuclear Corporation 416 Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=328971

Published by HT Digital Content Services with permission from Health Daily Digest....